Log In
BCIQ
Print this Print this
 

IL-4-Kinoid

  Manage Alerts
Collapse Summary General Information
Company Neovacs S.A.
DescriptionImmunotherapy against interleukin-4 (IL-4; BSF1)
Molecular Target Interleukin-4 (IL-4) (BSF1)
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationAllergy
Indication DetailsTreat allergies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today